Important OptumRx updates to support providers, clinical staff and patients through COVID-19.
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
November 9, 2020 - Sedor Pharmaceuticals announced the FDA approval of Sesquient (fosphenytoin sodium).
Download PDF
Return to publications
